dacarbazine,doxorubicin,brentuximab vedotin,vinblastine,bleomycin,vincristine
seagen
['lymphoma', 'hodgkin']
great late breaker presentation by peter borchmann on behalf of the #ghsg @ #17icml ! brecadd is non-inferior to ebeacopp in advanced #hodgkin lymphoma with impressive 3-yr-pfs and os of 94,9 % and 98,5 % and no treatment related deaths. brecadd announced as new ghsg-soc! 
Hematologist-oncologist. Lymphoma / CAR-T specialist. Researcher. Department of Hematology and Stem Cell Transplantation Essen. Tweets are no medical advice.